Drew Amorosi is a Senior Staff Writer for Healio, a healthcare news organization. With a focus on medical research and treatments, Drew covers a wide range of topics including leukemia, lymphoma, breast cancer, and healthcare disparities. His articles aim to provide informative and up-to-date information to healthcare professionals and patients alike.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Drew Amorosi's coverage primarily focuses on healthcare and pharmaceuticals, often citing data and press releases. He may be interested in pitches related to new scientific research, breakthrough treatments, or innovative therapies within the field of cancer treatment and precision medicine.
Given his focus on racial disparities in cancer treatment and specific diseases such as breast cancer, sickle cell disease, multiple myeloma, etc., Drew would likely welcome pitches that highlight efforts to address these disparities or advancements in treating these conditions.
As there is no specified geographic focus for Drew's articles, sources with a global perspective or those involved in international medical studies could be relevant for reaching out to him.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Drew Amorosi, Cassandra Jenkins
Results of a randomized study revealed that adults with obesity assigned to a low-energy diet with low-, medium- or high-carbohydrate intake all achieved ketosis and weight loss without the expected increase in hunger.
By: Cassandra Jenkins, Drew Amorosi
A retrospective study of women who received mammograms between 2007 and 2016 at UC San Diego Health revealed that breast arterial calcification (BAC), which is visible on routine mammograms, could serve as a predictor for CVD risk.
By: Moira Mahoney, Drew Amorosi
Sudden cardiac death is the main cause of medical death among recreational and professional athletes and remains a public health issue, according to a review published in The Lancet
The lower mortality rate experienced after age 85 years among Black adults in the United States persisted up to 100 years of age, a study published in the Journal of Internal Medicine showed.
By: Moira Mahoney, Drew Amorosi
Patients with overweight or obesity assigned tirzepatide lost more weight compared with those assigned semaglutide, according to new results from the SURMOUNT-5 trial announced by Eli Lilly.
By: Drew Amorosi, Moira Mahoney
Policymakers should implement increased regulation of nonprofit pregnancy centers, which may offer harmful or unsafe treatments or spread misinformation, according to researchers.
By: Drew Amorosi, Esmeralda Arias
Researchers found that vaccine hesitancy is more common among patients who seek information from the media and the internet.
By: Drew Amorosi, Cassandra Jenkins
A CDC study found that splash pads, or water playgrounds, have been linked to more than 10,000 cases of preventable waterborne illness between 1997 and 2022.
By: Cassandra Jenkins, Drew Amorosi
A post hoc analysis of the SURMOUNT-1 and SURMOUNT-2 trials found that early responders to tirzepatide, or those who lost at least 5% of body weight
By: Cassandra Jenkins, Drew Amorosi
Healio spoke with Cynthia Fok, MD, associate professor in the department of urology at the University of Minnesota Medical School, about the prevalence
(833) 317-6278 
